Skip to main content
    I

    IQVIA Holdings Inc (IQV)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $264.73
    -0.39 (-0.15%)

    Market Cap: $43.69B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    IQVIA Holdings Inc (IQV) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    IQVIA Holdings (IQV) trades at 22.0x trailing earnings and 2.5x sales. Its P/E of 22.0x is above its 5-year median of 20.3x. Its forward P/E is 18.3x. The median P/E across 11 similar companies is 26.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 20.2% higher over the next year. Its free cash flow yield is 4.8%.

    MultipleValue
    P/E (trailing)22.0x
    Forward P/E18.3x
    Price to sales2.5x
    Price to book6.5x
    EV/EBITDA16.2x
    Price to FCF21.0x
    EV/FCF27.6x
    PEG1.0
    FCF yield4.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 2.7% below 22.6x, its P/S is 3.8% below 2.6x and its P/B is 18.2% above 5.5x.

    MultipleCurrent5-year median10-year median
    P/E22.0x20.3x22.6x
    P/S2.5x2.6x2.6x
    P/B6.5x6.3x5.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 119 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 17.6x in 2024 to 31.2x in 2021.

    Year endPriceP/EP/SP/B
    2025$225.4118.9x2.4x6.0x
    2024$196.5117.6x2.3x5.9x
    2023$231.3822.7x2.8x7.0x
    2022$204.8920.1x2.7x6.7x
    2021$282.1431.2x3.9x9.1x
    2020$179.1727.9x3.0x5.7x
    2019$154.5124.1x2.7x5.1x
    2018$116.1720.9x2.3x3.5x
    2017$97.9020.9x2.2x2.6x
    2016$76.0523.2x1.6x2.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IQV

    What is IQV's forward P/E ratio?

    IQVIA Holdings has a forward P/E ratio of 18.3x.

    Is IQV stock overvalued?

    GNG's valuation label for IQV is Undervalued. Its P/E of 22.0x compares with a median of 26.8x across 11 similar companies.

    What is IQV's price to sales ratio?

    IQVIA Holdings has a price to sales ratio of 2.5x.

    What is IQVIA Holdings's average P/E ratio over 5 years?

    IQVIA Holdings's median P/E over the last 5 years is 20.3x, from 60 month-end values through Oct 2026.

    What is IQV's PEG ratio?

    IQVIA Holdings has a PEG ratio of 1.0.